We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.22B
AUM Growth
+$186M
Cap. Flow
+$50.9M
Cap. Flow %
0.82%
Top 10 Hldgs %
20.46%
Holding
730
New
167
Increased
166
Reduced
151
Closed
229

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$125M
2
PEP icon
PepsiCo
PEP
+$64.4M
3
USB icon
US Bancorp
USB
+$59.8M
4
TSN icon
Tyson Foods
TSN
+$49.4M
5
TGT icon
Target
TGT
+$48.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$106M
2
APTV icon
Aptiv
APTV
+$34.7M
3
AGNC icon
AGNC Investment
AGNC
+$34.2M
4
NEM icon
Newmont
NEM
+$33.9M
5
GEN icon
Gen Digital
GEN
+$28.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.78%
2 Healthcare 13.79%
3 Financials 11.85%
4 Utilities 10.97%
5 Technology 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
151
Amazon
AMZN
$2.49T
$7.71M 0.12%
+493,060
New +$7.35M
URS
152
DELISTED
URS CORP
URS
$7.67M 0.12%
142,753
+115,331
+421% +$5.72M
HPQ icon
153
HP
HPQ
$24.3B
$7.66M 0.12%
803,580
-235,784
-23% -$2.6M
BAH icon
154
Booz Allen Hamilton
BAH
$8.59B
$7.29M 0.12%
377,399
-210,358
-36% -$4.11M
AUY
155
DELISTED
Yamana Gold, Inc.
AUY
$7.15M 0.12%
685,900
-999,400
-59% -$10.5M
AXP icon
156
American Express
AXP
$229B
$6.99M 0.11%
92,543
-187,085
-67% -$14.1M
HLF icon
157
Herbalife
HLF
$1.26B
$6.95M 0.11%
199,116
+154,482
+346% +$4.78M
LO
158
DELISTED
LORILLARD INC COM STK
LO
$6.88M 0.11%
153,524
+85,172
+125% +$3.75M
ANDV
159
DELISTED
Andeavor
ANDV
$6.6M 0.11%
150,012
-156,081
-51% -$7.78M
KRFT
160
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$6.48M 0.1%
+123,441
New +$6.76M
PG icon
161
Procter & Gamble
PG
$346B
$6.43M 0.1%
85,073
-42,479
-33% -$3.38M
BBBY
162
DELISTED
Bed Bath & Beyond Inc
BBBY
$6.39M 0.1%
+82,663
New +$6.19M
CELG
163
DELISTED
Celgene Corp
CELG
$6.26M 0.1%
+81,268
New +$5.7M
AVP
164
DELISTED
Avon Products, Inc.
AVP
$5.97M 0.1%
+289,608
New +$6.2M
DG icon
165
Dollar General
DG
$27.2B
$5.88M 0.09%
104,059
+19,460
+23% +$1.07M
ITC
166
DELISTED
ITC HOLDINGS CORP
ITC
$5.75M 0.09%
183,948
-236,823
-56% -$7.19M
UGI icon
167
UGI
UGI
$7.91B
$5.55M 0.09%
212,733
-190,851
-47% -$5.12M
WSM icon
168
Williams-Sonoma
WSM
$27.6B
$5.4M 0.09%
+192,218
New +$5.57M
SBUX icon
169
Starbucks
SBUX
$118B
$5.31M 0.09%
+137,868
New +$4.95M
GE icon
170
GE Aerospace
GE
$375B
$5.27M 0.08%
46,015
-210,101
-82% -$24.1M
Y
171
DELISTED
Alleghany Corp
Y
$5.09M 0.08%
12,436
-15,321
-55% -$6.12M
GOOG icon
172
Alphabet (Google) Class C
GOOG
$3.99T
$4.74M 0.08%
217,211
-26,539
-11% -$586K
KBR icon
173
KBR
KBR
$4.67B
$4.71M 0.08%
+144,405
New +$4.58M
AGNC icon
174
AGNC Investment
AGNC
$12.4B
$4.7M 0.08%
208,263
-1,520,313
-88% -$34.2M
C icon
175
Citigroup
C
$223B
$4.7M 0.08%
96,940
-438,581
-82% -$22.2M

Similar funds

Analytic Investors's Q3 2013 Portfolio in Review

As of Q3 2013, Analytic Investors held 730 positions worth $6.22B, up 3.1% from $6.03B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Analytic Investors's Q3 2013 filing shows 167 new, 166 increased, 151 reduced and 229 closed positions. Its largest new stake was T. Rowe Price: 421,030 shares worth $30.3M. The largest sale was Amgen, an estimated $106M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Analytic Investors's largest Q3 2013 buy was T. Rowe Price: 421,030 shares worth $30.3M.
  • Analytic Investors added most to AT&T in Q3 2013, an estimated $125M increase.
  • Analytic Investors's biggest Q3 2013 reduction was Amgen, cutting an estimated $106M.
  • Analytic Investors fully exited Aptiv in Q3 2013, selling an estimated $34.7M.
  • Analytic Investors's ten largest holdings make up 20% of its $6.22B portfolio in Q3 2013.
  • Analytic Investors opened 167 new positions and closed 229 in Q3 2013.
  • Analytic Investors's portfolio value rose 3.1% quarter-over-quarter to $6.22B.

Based on Analytic Investors's 13F filing for Q3 2013, filed 12 Nov 2013.